RFA-MD-21-005: Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2021.
National Institutes of Health offered grants to small businesses. Applications closed on May 3, 2021.
From the official notice on Grants.gov, last changed March 11, 2021. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeR41 / R42
- Clinical trialsOptional
- Funded byNIMHD
- Median yearly award$381,466
- Typical project length4.5 years
- R41, Small Business Technology Transfer (STTR) Phase I. A small business and a research institution test the feasibility of a technology together. Other open R41 notices.
- R42, Small Business Technology Transfer (STTR) Phase II. Full development of an STTR project after Phase I. Other open R42 notices.
Projects funded under RFA-MD-21-005 were run by National Institute on Minority Health and Health Disparities (NIMHD, 3 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-MD-21-005 in the NIH Guide.
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| RFA-MD-24-007 | March 8, 2024 | Closed November 17, 2025 | Closed |
| RFA-MD-23-002 | January 30, 2023 | Closed September 6, 2023 | Closed |
| RFA-MD-22-003 | January 5, 2022 | Closed April 4, 2022 | Closed |
Key dates
| Posted | March 11, 2021 |
|---|---|
| Deadline | May 3, 2021 |
| Archived by Grants.gov | June 8, 2021 |
Who can apply
This opportunity was open to small businesses.
- Small businesses
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Is this a realistic fit?
- Most of the program's money (78% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined populations experiencing health disparities. Appropriate technologies should be effective, affordable, and culturally acceptable.
Funded under RFA-MD-21-005 so far
NIH funded 3 projects under RFA-MD-21-005 in fiscal 2021 to 2023, at 3 institutions. The median yearly award was $381,466.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Good Bowls: Empowering Communities to Achieve Good Food Access and Health Equity | Equiti Foods, LLC | 2023 | $318,616 |
| Smartphone App to Increase and Maintain Physical Activity in African American Men (FitBrothers) | Klein Buendel, Inc. | 2023 | $692,438 |
| Empowering providers to improve care for disadvantaged patients: design and prototype testing of novel user interface for electronic health records | Asp.md | 2022 | $255,147 |
Who has won Minority Health and Health Disparities Research grants before
From fiscal 2021 to 2025, Minority Health and Health Disparities Research (93.307) awarded $2.0 billion across 1,237 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Johns Hopkins University | Maryland | 37 | $69.3 million |
| The Trustees of Columbia University in the City of New York | New York | 25 | $59.1 million |
| University of Hawaii | Hawaii | 18 | $52.8 million |
| The Regents of the University of California, San Francisco | California | 24 | $49.5 million |
| The Morehouse School of Medicine, Inc. | Georgia | 4 | $44.1 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-MD-21-005 still open?
No. It closed on May 3, 2021.
Who can apply for Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)?
National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)?
Closed May 3, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under RFA-MD-21-005?
NIH RePORTER lists 3 projects funded under RFA-MD-21-005 in fiscal 2021 to 2023, at 3 institutions. The most were at Equiti Foods, LLC, Klein Buendel, Inc., Asp.md.
Who has won Minority Health and Health Disparities Research grants before?
The largest recipients over five fiscal years were The Johns Hopkins University, The Trustees of Columbia University in the City of New York, University of Hawaii. The program made 1,237 awards worth $2.0 billion in that time.
Similar open grants
- Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)